Research & achievements研究・業績aaa
Research paper研究論文-英文-
2018年度
-
2018年度
-
Impact of surgical treatment after sorafenib therapy for advanced hepatocellular carcinoma.
Surgery today 48(4) 431-438 2018
- Takeyama H, Beppu T, Higashi T, Kaida T, Arima K, Taki K, Imai K, Nitta H, Hayashi H, Nakagawa S, Okabe H, Hashimoto D, Chikamoto A, Ishiko T, Tanaka M, Sasaki Y, Baba H.
-
Vonoprazan is superior to rabeprazole for healing endoscopic submucosal dissection induced ulcers.
Digestion 97:170-176, 2018
- Yamasaki A, Yoshio T, Muramatsu Y, Horiuchi Y, Ishiyama A, Hirasawa T, Tsuchida T, Sasaki Y and Fujisaki J.
-
The Incidence of Complications in Single-stage Endoscopic Stone Removal for Patients with Common Bile Duct Stones: A Propensity Score Analysis.
Intern Med. 2018; 57(4): 469-477
- Saito H, Kadono Y, Kamikawa K, Urata A, Imamura H, Matsushita I, Kakuma T, Tada S.
-
Usefullness and limitations of dual-layer spectral detector computed tomography for diagnosing biliary stones not detected by conventional computed tomography: a report of three cases.
Clin J Gastroenterol. 2018; 11(2): 172-177
- Saito H, Noda K, Ogasawara K, Atsuji S, Takaoka H, Kajihara H, Nasu J, Morishita S, Matsushita I, Katahira K.
-
Reduced iodinated contrast media for abdominal imaging by dual-layer spectral detector computed tomography for patients with kidney disease.
Radiol Case Rep. 2018 13(2): 437-443
- Saito H, Noda K, Ogasawara K, Atsuji S, Takaoka H, Kajihara H, Nasu J, Kitaoka M, Morishita S, Matsushita I, Katahira K.
-
Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trial. The lancet.
Gastroenterology & hepatology 3(6) 424-432 2018
- Kudo M, Ueshima K, Yokosuka O, Ogasawara S, Obi S, Izumi N, Aikata H, Nagano H, Hatano E, Sasaki Y, Hino K, Kumada T, Yamamoto K, Imai Y, Iwadou S, Ogawa C, Okusaka T, Kanai F, Akazawa K, Yoshimura KI, Johnson P, Arai Y, SILIUS study group.
-
Analysis for the primary predictive factor for the incidence of esophageal injury after ablation of atrial fibrillation.
J Cardiol. 2018 Dec;72(6):480-487.
- Ito M, Yamabe H, Koyama J, Kanazawa H, Kaneko S, Kanemaru Y, Kiyama T, Arima Y, Takashio S, Yamamoto E, Izumiya Y, Kojima S, Kaikita K, Shono T, Utsunomiya D, Sasaki Y, Yamashita Y, Tsujita K.
-
Development of Kupffer cell targeting type-I interferon for the treatment of hepatitis via inducing anti-inflammatory and immunomodulatory actions.
Drug Deliv. 2018 Nov;25(1):1067-1077.
- Minayoshi Y, Maeda H, Yanagisawa H, Hamasaki K, Mizuta Y, Nishida K, Kinoshita R, Enoki Y, Imafuku T, Chuang VTG, Koga T, Fujiwara Y, Takeya M, Sonoda K, Wakayama T, Taguchi K, Ishima Y, Ishida T, Iwakiri Y, Tanaka M, Sasaki Y, Watanabe H, Otagiri M, Maruyama T.
-
Spleen Dose-Volume Parameters as a Predictor of Treatment-related Lymphopenia During Definitive Chemoradiotherapy for Esophageal Cancer.
In Vivo. 2018 Nov-Dec;32(6):1519-1525.
- Saito T, Toya R, Yoshida N, Shono T, Matsuyama T, Ninomura S, Watakabe T, Sasaki Y, Baba H, Oya N.
-
Increased EZH2 expression during the adenoma-carcinoma sequence in colorectal cancer.
Oncol Lett. 2018 Oct;16(4):5275-5281.
- Ohuchi M, Sakamoto Y, Tokunaga R, Kiyozumi Y, Nakamura K, Izumi D, Kosumi K, Harada K, Kurashige J, Iwatsuki M, Baba Y, Miyamoto Y, Yoshida N, Shono T, Naoe H, Sasaki Y, Baba H.
-
Impact of retroflexion in the right colon after repeated forward-view examination.
JGH Open. 2018 Sep 10;2(6):282-287.
- Miyamoto H, Naoe H, Oda Y, Shono T, Narita R, Oyama S, Hashigo S, Okuda A, Hasuda K, Tanaka M, Sakurai K, Murakami Y, Sasaki Y.
-
Aspartate beta-hydroxylase promotes cholangiocarcinoma progression by modulating RB1 phosphorylation.
Cancer Lett. 2018 Aug 10; 429:1-10.
- Huang CK,Iwagami Y,Aou J,Casulli S,Lu S,Nagaoka K,Ji C,Ogawa K,Cao KY,Gao JS,Carlson RI,Wandas JR.
-
Usefulness of Virtual Touch Quantification for Staging Liver Fibrosis in Patients with Hepatitis C, and Factors Affecting Liver Stiffness Measurement Failure Compared with Liver Biopsy.
Hepatol Res. Apr; 48(5):373-382, 2018
- Tsukano N, Miyase S, Saeki T, Mizobe K, Iwashita H, Arima N, Fujiyama S.
-
Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomized, open label, phase 3 trial.
The Lancet Gastroenterology Hepatology. 2018 Jun; 3(6): 424-432
- Kudo M, Ueshima K, Yokosuka O, Obi S, Izumi N, Aikata H, Nagano H, Hatano E, Sasaki Y, Hino K, Kumada T, Yamamoto K, Imai Y, Iwadou S, Ogawa C, Okusaka T, Kanai F, Akazawa K, Yoshimura K, Arai Y, the SILIUS study group.
-
LSD1 mediates metabolic reprogramming by glucocorticoids during myogenic differentiation.
Nucleic Acids Res. 2018 Jun 20; 46(11):5441-5454.
- Anan K, Hino S, Shimizu N, Sakamoto A, Nagaoka K, Takase R, Kohrogi K, Araki H, Hino Y, Usuki S, Oki S, Tanaka H, Nakamura K, Endo F, Nakao M.
-
Modeling of the Weight Status and Risk of Nonalcoholic Fatty Liver Disease in Elderly Individuals: The Potential Impact of the Disulfide Bond-Forming Oxidoreductase A-Like Protein (DsbA-L) Polymorphism on the Weight Status.
CPT Pharmacometrics Syst Pharmacol. 2018 Jun;7(6):384-393.
- Oniki K, Watanabe T, Kudo M, Izuka T, Ono T, Matsuda K, Sakamoto Y, Nagaoka K, Imafuku T, Ishima Y, Watanabe H, Maruyama T, Otake K, Ogata Y, Saruwatari J.
-
Impact of retroflexion in the right colon after repeated forward-view examinations.
JGH open 2/P.282-287/2018
- Miyamoto H, Naoe H, Oda Y, Shono T, Narita R, Oyama S, Hashigo S, Okuda A, Hasuda K, Tanaka M, Sakurai K, Murakami Y, Sasaki Y
-
Functional Analysis of Human Hepatocytes Isolated From Chimeric Mouse Liver
Transplant Proc 50/P.3858-3862/2018
- Harimoto N, Nakagawara H, Shirabe K, Yoshizumi T, Itoh S, Ikegami T, Soejima Y, Maehara Y, Ishida Y, Tateno C, Tanaka Y
-
Circulating let-7 Levels in Serum Correlate With the Severity of Hepatic Fibrosis in Chronic Hepatitis C.
Open Forum Infect Dis 5/P.ofy268-/2018
- Matsuura K, Aizawa N, Enomoto H, Nishiguchi S, Toyoda H, Kumada T, Iio E, Ito K, Ogawa S, Isogawa M, Alter HJ, Tanaka Y.
-
Serum M2BPGi level and risk of hepatocellular carcinoma after oral anti-viral therapy in patients with chronic hepatitis B
Aliment Pharmacol Ther 48/P.1128-1137/2018
- Hsu Y-C, Jun T, Huang Y-T, Yeh M-L, Lee C-L, Ogawa S, Cho S-H, Lin J-T, Yu M-L, Nguyen MH, Tanaka Y
-
Increased EZH2 expression during the adenoma-carcinoma sequence in colorectal cancer.
Oncol Lett 16/P.5275-5281/2018
- Ohuchi M, Sakamoto Y, Tokunaga R, Kiyozumi Y, Nakamura K, Izumi D, Kosumi K, Harada K, Kurashige J, Iwatsuki M, Baba Y, Miyamoto Y, Yoshida N, Shono T, Naoe H, Sasaki Y, Baba H.
-
Type I interferon signaling prevents hepatitis B virus-specific T cell responses by reducing antigen expression
J Virol 92/P.e01099-/2018
- Kawashima K, Isogawa M, Hamada-Tsutsumi S, Baudi I, Saito S, Nakajima A, Tanaka Y
-
Intrahepatic Cross-Presentation and Hepatocellular Antigen Presentation Play Distinct Roles in the Induction of Hepatitis B Virus-Specific CD8 + T Cell Responses
J Virol 92/P.e00920-/2018
- Murata Y, Kawashima K, Sheikh K, Tanaka Y, Isogawa M
-
Screening of microRNAs for a repressor of hepatitis B virus replication
Oncotarget 9/P.29857-29868/2018
- Naito Y, Hamada-Tsutsumi S, Yamamoto Y, Kogure A, Yoshioka Y, Watashi K, Ochiya T, Tanaka Y
-
Sofosbuvir–velpatasvir plus ribavirin in Japanese patients with genotype 1 or 2 hepatitis C who failed direct-acting antivirals
Hepatol Int 12/P.356-367/2018
- Izumi N, Takehara T, Chayama K, Yatsuhashi H, Takaguchi K, Ide T, Kurosaki M, Ueno Y, Toyoda H, Kakizaki S, Tanaka Y, Kawakami Y, Enomoto H, Ikeda F, Jiang D, De-Oertel S, McNabb BL, Camus G, Stamm LM, Brainard DM, McHutchison JG, Mochida S, Mizokami M
-
Dysregulation of miRNA in chronic hepatitis B is associated with hepatocellular carcinoma risk after nucleos(t)ide analogue treatment.
Cancer Lett 434/P.91-100/2018
- Wakasugi H, Takahashi H, Niinuma T, Kitajima H, Oikawa R, Matsumoto N, Takeba Y, Otsubo T, Takagi M, Ariizumi Y, Suzuki M, Okuse C, Iwabuchi S, Nakano M, Akutsu N, Kang J-H, Matsui T, Yamada N, Sasaki H, Yamamoto E, Kai M, Sasaki Y, Sasaki S, Tanaka Y, Yotsuyanagi H, Tsutsumi T, Yamamoto H, Tokino T, Nakase H, Suzuki H, Itoh F
-
Clinical evaluation of a novel and highly sensitive immunoassay for anti-hepatitis B core antigen using a fully automated immunochemical analyzer
Hepatol Res 48/P.1081-1091/2018
- Izumida K, Kaneko A, Takahashi K, Kusumoto S, Narita T, Takami A, Iida S, Aoyagi K, Tanaka Y
-
Suppression of hepatitis B surface antigen production by combination therapy with nucleotide analogues and interferon in children with genotype C hepatitis B virus infection
Hepatol Res 48/P.1172-1177/2018
- Tajiri H, Takano T, Tanaka Y, Murakami J, Brooks S
-
De Novo Macrocyclic Peptide Inhibitors of Hepatitis B Virus Cellular Entry
Cell Chem Biol 25/P.906-915. e7/2018
- Passioura T, Watashi K, Fukano K, Shimura S, Saso W, Morishita R, Ogasawara Y, Tanaka Y, Mizokami M, Sureau C, Suga H, Wakita T
-
Differentiation Therapy by Epigenetic Reconditioning Exerts Antitumor Effects on Liver Cancer Cells
Mol Ther 26/P.1840-1854/2018
- Gailhouste L, Liew LC, Yasukawa K, Hatada I, Tanaka Y, Nakagama H, Ochiya T
-
Real-world virological efficacy and safety of elbasvir and grazoprevir in patients with chronic hepatitis C virus genotype 1 infection in Japan
J Gastroenterol 53/P.1276-1284/2018
- Toyoda H, Atsukawa M, Takaguchi K, Senoh T, Michitaka K, Hiraoka A, Fujioka S, Kondo C, Okubo T, Uojima H, Tada T, Yoneyama H, Watanabe T, Asano T, Ishikawa T, Tamai H, Abe H, Kato K, Tsuji K, Ogawa C, Shimada N, Iio E, Deguchi A, Itobayashi E, Mikami S, Moriya A, Okubo H, Tani J, Tsubota A, Tanaka Y, Masaki T, Iwakiri K, Kumada T
-
Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein level as a diagnostic marker of hepatitis B virus-related hepatocellular carcinoma
Hepatol Res 48/P.872-881/2018
- Chuaypen N, Chittmittraprap S, Pinjaroen N, Sirichindakul B, Poovorawan Y, Tanaka Y, Tangkijvanich P
-
Gut dysbiosis associated with hepatitis C virus infection
Clin Infect Dis 67/P.869-877/2018
- Inoue T, Nakayama J, Moriya K, Kawaratani H, Momoda R, Ito K, Iio E, Nojiri S, Fujiwara K, Yoneda M, Yoshiji H, Tanaka Y
-
Efficacy and safety of ledipasvir/sofosbuvir for genotype 1b chronic hepatitis C patients with moderate renal impairment
Hepatol Int 12/P.133-142/2018
- Okubo T, Atsukawa M, Tsubota A, Toyoda H, Shimada N, Abe H, Kato K, Hayama K, Arai T, Nakagawa-Iwashita A, Itokawa N, Kondo C, Kawamoto C, Iio E, Tanaka Y, Kumada T, Iwakiri K
-
Modeling of the Weight Status and Risk of Nonalcoholic Fatty Liver Disease in Elderly Individuals: The Potential Impact of the Disulfide Bond-Forming Oxidoreductase A-Like Protein (DsbA-L) Polymorphism on the Weight Status.
CPT Pharmacometrics Syst Pharmacol 7/P.384-393/2018
- Oniki K, Watanabe T, Kudo M,Izuka T, Ono T, Matsuda K,Sakamoto Y, Nagaoka K, Imafuku T, Ishima Y,Watanabe H, Maruyama T, Otake K,Ogata Y, Saruwatari J
-
Efficacy and safety of ombitasvir/paritaprevir/ritonavir combination therapy for genotype 1b chronic hepatitis C patients complicated with chronic kidney disease
Hepatol Res 48/P.549-555/2018
- Arai T, Atsukawa M, Tsubota A, Ikegami T, Shimada N, Kato K, Abe H, Okubo T, Itokawa N, Kondo C, Mikami S, Asano T, Chuganji Y, Matsuzaki Y, Toyoda H, Kumada T, Iio E, Tanaka Y, Iwakiri K
-
Vonoprazan is Superior to Rabeprazole for Healing Endoscopic Submucosal Dissection: Induced Ulcers
Digestion 97/P.170-176/2018
- Yamasaki A, Yoshio T, Muramatsu Y, Horiuchi Y, Ishiyama A, Hirasawa T, Tsuchida T, Sasaki Y, Fujisaki J
-
High levels of serum Mac-2-binding protein glycosylation isomer (M2BPGi) predict the development of hepatocellular carcinoma in hepatitis B patients treated with nucleot(s)ide analogues
J Gastroenterol 53/P.883-889/2018
- Shinkai N, Nojima M, Iio E, Matsunami K, Toyoda H, Murakami S, Inoue T, Ogawa S, Kumada T, Tanaka Y
-
Antiviral therapy for hepatitis B virus during second pregnancies
J Obstet Gynaecol Res 44/P.566-569/2018
- Wakano Y, Sugiura T, Endo T, Ito K, Suzuki M, Tajiri H, Tanaka Y, Saitoh S
-
Late relapse after a sustained virologic response at 24 weeks after treatment with daclatasvir and asunaprevir combination therapy for chronic hepatitis c virus genotype 1b infection with liver cirrhosis
Intern Med 57/P.951-956/2018
- Uojima H, Murakami S, Nakatani S, Hidaka H, Takeuchi A, Tanaka Y, Inoue T, Yamane K, Kubota K, Nakazawa T, Shibuya A, Tanaka Y, Koizumi W
-
Changes in serum lipid profiles caused by three regimens of interferon-free direct-acting antivirals for patients infected with hepatitis C virus
Hepatol Res 48/P.E203-E212/2018
- Inoue T, Goto T, Iio E, Matsunami K, Fujiwara K, Shinkai N, Matsuura K, Matsui T, Nojiri S, Tanaka Y
-
Predictive role of serum HBsAg and HBcrAg kinetics in patients with HBeAg-negative chronic hepatitis B receiving pegylated interferon–based therapy
Clin Microbiol Infect 24/P.306. e7-306. e13/2018
- Chuaypen N, Posuwan N, Chittmittraprap S, Hirankarn N, Treeprasertsuk S, Tanaka Y, Shinkai N, Poovorawan Y, Tangkijvanich P
-
Combination of PNPLA3 and TLL1 polymorphism can predict advanced fibrosis in Japanese patients with nonalcoholic fatty liver disease
J Gastroenterol 53/P.438-448/2018
- Seko Y, Yamaguchi K, Mizuno N, Okuda K, Takemura M, Taketani H, Hara T, Umemura A, Nishikawa T, Moriguchi M, Yasui K, Kamaguchi M, Nishioji K, Mochizuki N, Kobayashi M, Mori K, Tanaka S, Matsuura K, Tanaka Y, Itoh Y
-
Combinational use of hepatitis B viral antigens predicts responses to nucleos(t)ide analogue/peg-interferon sequential therapy.
J Gastroenterol 53/P.247-257/2018
- Matsumoto A, Nishiguchi S, Enomoto H, Kang J-H, Tanaka Y, Shinkai N, Kurosaki M, Enomoto M, Kanda T, Yokosuka O, Yatsuhashi H, Nagaoka S, Okuse C, Kagawa T, Mine T, Takaguchi K, Saito S, Hino K, Ikeda F, Sakisaka S, Morihara D, Miyase S, Tsuge M, Chayama K, Hiramatsu N, Suzuki Y, Murata K, Tanaka E
-
Daclatasvir and asunaprevir in hemodialysis patients with hepatitis C virus infection: a nationwide retrospective study in Japan
J Gastroenterol 53/P.119-128/2018
- Suda G, Furusyo N, Toyoda H, Kawakami Y, Ikeda H, Suzuki M, Arataki K, Mori N, Tsuji K, Katamura Y, Takaguchi K, Ishikawa T, Tsuji K, Shimada N, Hiraoka A, Yamsaki S, Nakai M, Sho T, Morikawa K, Ogawa K, Kudo M, Nagasaka A, Furuya K, Yamamoto Y, Kato K, Ueno Y, Iio E, Tanaka Y, Kurosaki M, Kumada T, Chayama K, Sakamoto N
-
Effect of hepatitis B virus subgenotype on antiviral response in nucleoside-treated hepatitis B envelope antigen-positive patients
Hepatol Res 48/P.134-143/2018
- Shen S, Liang X, Hamed K, Tanaka Y, Omagari K, Fan R, Xie Q, Tan D, Zhou B, Jia J-D, Hou J, Sun J
-